Table 3:
Adiponectin | Leptin | Resistin | IL-6 | CRP | HOMA-IR | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
beta | s.e. | p-value | beta | s.e. | p-value | beta | s.e. | p-value | beta | s.e. | p-value | beta | s.e. | p-value | beta | s.e. | p-value | |
Without lung disease N=421 | ||||||||||||||||||
FEV1 | 0.05 | 0.77 | 0.95 | −4.04 | 1.11 | <0.0001 | −0.30 | 0.81 | 0.71 | −1.46 | 0.76 | 0.06 | −1.76 | 0.81 | 0.03 | −2.07 | 1.02 | 0.04 |
FVC | 0.39 | 0.76 | 0.61 | −3.50 | 1.11 | 0.002 | −0.99 | 0.80 | 0.21 | −1.36 | 0.75 | 0.07 | −2.22 | 0.80 | 0.006 | −2.10 | 1.03 | 0.04 |
FEV1/FVC | −0.26 | 0.35 | 0.46 | −0.46 | 0.52 | 0.38 | 0.72 | 0.37 | 0.05 | −4E-4 | 0.35 | 0.99 | 0.68 | 0.37 | 0.07 | −0.01 | 0.48 | 0.98 |
TLC | 0.44 | 0.76 | 0.56 | −5.16 | 1.02 | <0.0001 | 0.31 | 0.81 | 0.70 | −0.95 | 0.76 | 0.21 | −1.29 | 0.81 | 0.11 | −3.01 | 1.05 | 0.005 |
DLCO | 0.11 | 1.10 | 0.92 | −5.40 | 1.51 | <0.0001 | −1.76 | 1.18 | 0.14 | −1.95 | 1.10 | 0.08 | −2.53 | 1.18 | 0.03 | −2.34 | 1.53 | 0.13 |
Restrictive lung disease N=98 | ||||||||||||||||||
FEV1 | −3.12 | 2.04 | 0.13 | −1.79 | 3.16 | 0.57 | −0.13 | 1.59 | 0.93 | −1.98 | 1.84 | 0.29 | −3.76 | 1.99 | 0.62 | −6.84 | 3.22 | 0.04 |
FVC | −4.10 | 1.98 | 0.04 | −0.77 | 3.1 | 0.80 | 0.13 | 1.56 | 0.93 | −2.8 | 1.79 | 0.12 | −3.04 | 1.96 | 0.13 | −5.31 | 3.15 | 0.10 |
FEV1/FVC | 1.47 | 1.10 | 0.19 | −1.85 | 1.69 | 0.28 | 0.13 | 0.86 | 0.87 | 1.04 | 0.99 | 0.30 | −0.77 | 1.09 | 0.48 | −1.80 | 1.82 | 0.33 |
TLC | −1.71 | 1.96 | 0.39 | −5.09 | 3.00 | 0.10 | 0.87 | 1.54 | 0.57 | −1.19 | 1.62 | 0.46 | −1.72 | 1.79 | 0.34 | −5.00 | 3.21 | 0.13 |
DLCO | −0.76 | 1.94 | 0.69 | −1.65 | 3.06 | 0.59 | −1.94 | 1.56 | 0.22 | −0.05 | 1.65 | 0.98 | 1.04 | 1.89 | 0.60 | −3.03 | 3.28 | 0.36 |
COPD N=174 | ||||||||||||||||||
FEV1 | 0.37 | 1.95 | 0.85 | −2.87 | 2.58 | 0.27 | 0.58 | 1.44 | 0.69 | −5.51 | 1.54 | <0.001 | −3.98 | 1.67 | 0.02 | −4.73 | 2.57 | 0.07 |
FVC | 0.80 | 1.86 | 0.67 | 2.48 | 2.46 | 0.32 | 0.44 | 1.37 | 0.75 | −5.01 | 1.47 | 0.001 | −5.05 | 1.57 | 0.001 | −4.75 | 2.46 | 0.06 |
FEV1/FVC | −1.26 | 1.18 | 0.29 | −1.10 | 1.57 | 0.48 | 0.61 | 0.87 | 0.49 | −2.24 | 0.96 | 0.02 | 0.42 | 1.03 | 0.69 | −0.63 | 1.55 | 0.69 |
TLC | 1.20 | 2.27 | 0.60 | −1.90 | 2.96 | 0.52 | 0.25 | 1.66 | 0.88 | −1.71 | 1.76 | 0.33 | −4.54 | 1.82 | 0.01 | −3.81 | 2.79 | 0.18 |
DLCO | −0.35 | 2.38 | 0.88 | −0.96 | 3.11 | 0.76 | −0.26 | 1.74 | 0.88 | −1.16 | 1.87 | 0.54 | −4.28 | 2.00 | 0.03 | −2.73 | 2.87 | 0.34 |
Multivariable model adjusted for age, sex, smoking status, previous MI, heart failure, and BMI. Units indicate difference in % predicted PFT per 1-SD change in log-transformed biomarker.
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffusion capacity of lungs for carbon monoxide; IL-6, interleukin-6; CRP, C-Reactive protein; HOMA-IR, homeostatic model assessment of insulin resistance